AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure
Theramex were searching for a platform to digitise the manual processes across their R&D landscape
The company increases its efficiency and is able to face the growing demand for its services.
Therapy recently approved in Canada under the brand name KORSUVA
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
100% efficacy against severe Covid-19 disease and hospitalizations
ArisGlobal's industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness
Subscribe To Our Newsletter & Stay Updated
